Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Researchers announce vaccines breakthrough
A Dendritic cell - Source: PLoS Pathogens
Variable immune responses investigated

Researchers from the Institute for Animal Health (IAH) and the University of Oxford's prestigious Jenner Institute have announced a breakthrough in understanding why some vaccinations are less effective at stimulating the desired immune response than others. The research, which was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and undertaken by Dr Bryan Charleston, Dr Efrain Guzman and Dr Jayne Hope, is published in the journal Vaccine.

“We knew that sometimes even when we know a bacteria or virus well, it has been a struggle to make effective vaccines against certain diseases.” said Dr Charleston, before explaining that “We discovered that dendritic cells – a type of immune cell – are activated better by some vaccines than others.
There are a lot of human and animal diseases that we would like better vaccines for, but until now we haven’t been able to find a good reason why, for example, the BCG vaccine against tuberculosis isn’t always effective, but the bovine herpes virus vaccine is extremely efficient at establishing long-term immunity.” 



The researchers found that the BCG vaccine is only taken up by a small number of dendritic cells, thus explaining the variations in efficacy. They also investigated the possibility of improving the efficiency of responses to vaccinations by deliberately targeting dendritic cells, and got a positive response to this line of enquiry. It is hoped that the team's discovery will allow for the development of new vaccines caused by viruses as well as bacteria. The next stage of the research is to develop the technique of improving dendritic cellular response into a safe and reliable technique for use in the vaccination of both humans and animals.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.